Shahoei, Sayyed Hamed

27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression

Ma, L., Wang, L., Nelson, A. T., Han, C., He, S., Henn, M. A., Menon, K., Chen, J. J., Baek, A. E., Vardanyan, A., et al. (2020) · Cancer Letters

Cancer, Lipids, and MetabolismImmune cells in cancer

Cited by 98

CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T H 1 and T H 9 cells

Benoit-Lizon, I., Jacquin, E., Rivera Vargas, T., Richard, C., Roussey, A., Dal Zuffo, L., Martin, T., Melis, A., Vinokurova, D., Shahoei, S. H., et al. (2022) · Journal for ImmunoTherapy of Cancer

interferon and immune responsesImmunotherapy and Immune Responses

Cited by 85

Nuclear receptors, cholesterol homeostasis and the immune system

Shahoei, S. H., & Nelson, E. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology

Cholesterol and Lipid MetabolismSteroid Chemistry and Biochemistry

Cited by 43

Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages

Shahoei, S. H., Kim, Y.-C., Cler, S. J., Ma, L., Anakk, S., Kemper, J. K., & Nelson, E. R. (2019) · Endocrinology

T-cell and B-cell ImmunologyProtein Tyrosine Phosphatases

Cited by 16

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells

Vidana Gamage, H. E., Albright, S. T., Smith, A. J., Farmer, R., Shahoei, S. H., Wang, Y., Fink, E. C., Jacquin, E., Weisser, E., Bautista, R. O., et al. (2024) · Cancer Letters

Cancer Immunotherapy and BiomarkersImmune cells in cancer

Cited by 13

NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors

Vidana Gamage, H. E., Shahoei, S. H., Wang, Y., Jacquin, E., Weisser, E., Bautista, R. O., Henn, M. A., Schane, C. P., Nelczyk, A. T., Ma, L., et al. (2024) · Cancer Letters

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 9